BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30639059)

  • 1. Sox7 is involved in antibody-dependent endothelial cell activation and renal allograft injury via the Jagged1-Notch1 pathway.
    Qin Y; Sun B; Zhang F; Wang Y; Shen B; Liu Y; Guo Y; Fan Y; Qiu J
    Exp Cell Res; 2019 Feb; 375(2):20-27. PubMed ID: 30639059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-donor HLA class I antibodies: pathways to endothelial cell activation and cell-mediated allograft rejection.
    Naemi FM; Carter V; Kirby JA; Ali S
    Transplantation; 2013 Aug; 96(3):258-66. PubMed ID: 23823649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.
    Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outside-in HLA class I signaling regulates ICAM-1 clustering and endothelial cell-monocyte interactions via mTOR in transplant antibody-mediated rejection.
    Salehi S; Sosa RA; Jin YP; Kageyama S; Fishbein MC; Rozengurt E; Kupiec-Weglinski JW; Reed EF
    Am J Transplant; 2018 May; 18(5):1096-1109. PubMed ID: 29045076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch signaling mediates crosstalk between endothelial cells and macrophages via Dll4 and IL6 in cardiac microvascular inflammation.
    Pabois A; Pagie S; Gérard N; Laboisse C; Pattier S; Hulin P; Nedellec S; Toquet C; Charreau B
    Biochem Pharmacol; 2016 Mar; 104():95-107. PubMed ID: 26826491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated Rejection.
    Koenig A; Mezaache S; Callemeyn J; Barba T; Mathias V; Sicard A; Charreau B; Rabeyrin M; Dijoud F; Picard C; Meas-Yedid V; Olivo-Marin JC; Morelon E; Naesens M; Dubois V; Thaunat O
    J Am Soc Nephrol; 2021 Feb; 32(2):479-494. PubMed ID: 33239394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-mediated rejection: treatment alternatives and outcomes.
    Singh N; Pirsch J; Samaniego M
    Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma C4d+ Endothelial Microvesicles Increase in Acute Antibody-Mediated Rejection.
    Tower CM; Reyes M; Nelson K; Leca N; Kieran N; Muczynski K; Jefferson JA; Blosser C; Kukla A; Maurer D; Chandler W; Najafian B
    Transplantation; 2017 Sep; 101(9):2235-2243. PubMed ID: 27846156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cell antibodies associated with novel targets and increased rejection.
    Jackson AM; Sigdel TK; Delville M; Hsieh SC; Dai H; Bagnasco S; Montgomery RA; Sarwal MM
    J Am Soc Nephrol; 2015 May; 26(5):1161-71. PubMed ID: 25381426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
    Dragun D; Catar R; Philippe A
    Kidney Int; 2016 Aug; 90(2):280-288. PubMed ID: 27188505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
    Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro model of antibody-mediated injury to glomerular endothelial cells: Upregulation of MHC class II and adhesion molecules.
    Wilson NA; Dylewski J; Degner KR; O'Neill MA; Reese SR; Hidalgo LG; Blaine J; Panzer SE
    Transpl Immunol; 2020 Feb; 58():101261. PubMed ID: 31887408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between anti-endothelial antigen antibodies and allograft rejection in kidney transplantation.
    Lee HJ; Shin KH; Kim IY; Choi BH; Kim HH
    J Clin Lab Anal; 2023 Aug; 37(15-16):e24961. PubMed ID: 37694947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment.
    Lefaucheur C; Viglietti D; Hidalgo LG; Ratner LE; Bagnasco SM; Batal I; Aubert O; Orandi BJ; Oppenheimer F; Bestard O; Rigotti P; Reisaeter AV; Kamar N; Lebranchu Y; Duong Van Huyen JP; Bruneval P; Glotz D; Legendre C; Empana JP; Jouven X; Segev DL; Montgomery RA; Zeevi A; Halloran PF; Loupy A
    J Am Soc Nephrol; 2018 Feb; 29(2):620-635. PubMed ID: 29042454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Matrix Injury of Kidney Allografts in Antibody-Mediated Rejection: A Proteomics Study.
    Clotet-Freixas S; McEvoy CM; Batruch I; Pastrello C; Kotlyar M; Van JAD; Arambewela M; Boshart A; Farkona S; Niu Y; Li Y; Famure O; Bozovic A; Kulasingam V; Chen P; Kim SJ; Chan E; Moshkelgosha S; Rahman SA; Das J; Martinu T; Juvet S; Jurisica I; Chruscinski A; John R; Konvalinka A
    J Am Soc Nephrol; 2020 Nov; 31(11):2705-2724. PubMed ID: 32900843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.
    Angaswamy N; Tiriveedhi V; Sarma NJ; Subramanian V; Klein C; Wellen J; Shenoy S; Chapman WC; Mohanakumar T
    Hum Immunol; 2013 Nov; 74(11):1478-85. PubMed ID: 23876679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway.
    Narayanan K; Jendrisak MD; Phelan DL; Mohanakumar T
    Transpl Immunol; 2006 Jan; 15(3):187-97. PubMed ID: 16431285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.